What began as a niche ingredient in anti‑aging skin creams is now entering the world of injectable aesthetics. Copper peptides, short chains of amino acids bound to copper ions, are being marketed for their purported ability to stimulate collagen production, reduce inflammation, and accelerate tissue repair. While topical formulations have shown modest benefits in small clinical trials, the surge in injectable versions is outpacing robust scientific validation. Dermatologists warn that the long‑term safety profile remains unclear, urging consumers to seek evidence‑based treatments and await larger, peer‑reviewed studies before embracing the hype.
On top of everything as it happens